These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16564009)

  • 81. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
    Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
    PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
    Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
    PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding.
    Scobie HM; Young JA
    PLoS One; 2006 Dec; 1(1):e99. PubMed ID: 17183731
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inhibition of anthrax protective antigen outside and inside the cell.
    Backer MV; Patel V; Jehning BT; Claffey KP; Karginov VA; Backer JM
    Antimicrob Agents Chemother; 2007 Jan; 51(1):245-51. PubMed ID: 17074791
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Chemistry. Nota bene: know thine enemy.
    Smith O
    Science; 2001 Nov; 294(5545):1298. PubMed ID: 11701920
    [No Abstract]   [Full Text] [Related]  

  • 86. Sensitive fluorescence assay of anthrax protective antigen with two new DNA aptamers and their binding properties.
    Oh BN; Lee S; Park HY; Baeg JO; Yoon MY; Kim J
    Analyst; 2011 Aug; 136(16):3384-8. PubMed ID: 21743920
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH.
    Williams AS; Lovell S; Anbanandam A; El-Chami R; Bann JG
    Protein Sci; 2009 Nov; 18(11):2277-86. PubMed ID: 19722284
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Onset of anthrax toxin pore formation.
    Gao M; Schulten K
    Biophys J; 2006 May; 90(9):3267-79. PubMed ID: 16473908
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anthrax toxin receptor proteins.
    Bradley KA; Young JA
    Biochem Pharmacol; 2003 Feb; 65(3):309-14. PubMed ID: 12527323
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.
    Cryan LM; Rogers MS
    Front Biosci (Landmark Ed); 2011 Jan; 16(4):1574-88. PubMed ID: 21196249
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine.
    Komiyama T; Swanson JA; Fuller RS
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3875-82. PubMed ID: 16127065
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-range stabilization of anthrax protective antigen upon binding to CMG2.
    Mullangi V; Mamillapalli S; Anderson DJ; Bann JG; Miyagi M
    Biochemistry; 2014 Sep; 53(38):6084-91. PubMed ID: 25186975
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tumor endothelial marker 8 amplifies canonical Wnt signaling in blood vessels.
    Verma K; Gu J; Werner E
    PLoS One; 2011; 6(8):e22334. PubMed ID: 21829615
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding.
    Ramey JD; Villareal VA; Ng C; Ward SC; Xiong JP; Clubb RT; Bradley KA
    Biochemistry; 2010 Aug; 49(34):7403-10. PubMed ID: 20690680
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus.
    Jayawardena N; Burga LN; Easingwood RA; Takizawa Y; Wolf M; Bostina M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10934-E10940. PubMed ID: 30381454
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells.
    Pettit RK; Ackermann MR; Rimler RB
    Lab Invest; 1993 Jul; 69(1):94-100. PubMed ID: 8392646
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions.
    Bradley KA; Mogridge J; Jonah G; Rainey A; Batty S; Young JA
    J Biol Chem; 2003 Dec; 278(49):49342-7. PubMed ID: 14507921
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Endosomal recycling regulates Anthrax Toxin Receptor 1/Tumor Endothelial Marker 8-dependent cell spreading.
    Gu J; Faundez V; Werner E
    Exp Cell Res; 2010 Jul; 316(12):1946-57. PubMed ID: 20382142
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Imaging tumor endothelial marker 8 using an 18F-labeled peptide.
    Quan Q; Yang M; Gao H; Zhu L; Lin X; Guo N; Zhang G; Eden HS; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1806-15. PubMed ID: 21814853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.